CN101858892B - Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography - Google Patents

Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography Download PDF

Info

Publication number
CN101858892B
CN101858892B CN 200910029421 CN200910029421A CN101858892B CN 101858892 B CN101858892 B CN 101858892B CN 200910029421 CN200910029421 CN 200910029421 CN 200910029421 A CN200910029421 A CN 200910029421A CN 101858892 B CN101858892 B CN 101858892B
Authority
CN
China
Prior art keywords
landiolol
mobile phase
hydrochloride
solution
isopropyl alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 200910029421
Other languages
Chinese (zh)
Other versions
CN101858892A (en
Inventor
冒宜兰
姚晓敏
冯明声
倪桃
郑文艳
张璐
曹于平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing hicin pharmaceutical Limited by Share Ltd
Original Assignee
HAICHEN PHARMACEUTICAL CO Ltd NANJING
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAICHEN PHARMACEUTICAL CO Ltd NANJING filed Critical HAICHEN PHARMACEUTICAL CO Ltd NANJING
Priority to CN 200910029421 priority Critical patent/CN101858892B/en
Publication of CN101858892A publication Critical patent/CN101858892A/en
Application granted granted Critical
Publication of CN101858892B publication Critical patent/CN101858892B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a method for detecting landiolol hydrochloride optical isomers by a high efficiency liquid chromatography, comprising the following steps: (1) configuring chromatographic conditions: a chromatographic column adopting silica gel the surface of which is coated with cellulose tris(4-methylbenzoate) is a fixed phase chiral column; a mobile phase is normal hexane-isopropanol-diethylamine; and the detection wave length is 200nm-240nm; (2) adopting organic solvent to prepare a sample into solution containing 0.5-5.0mg/ml of landiolol hydrochloride; and (3) determining and recording chromatogram. The separating degrees of landiolol hydrochloride and landiolol hydrochloride isomers A, B, C reached by the determination method of the invention can reach 1.5-3.9, which conforms to the requirement of Chinese pharmacopoeia. The method provided by the invention can be used for quantifying the landiolol hydrochloride optical isomers.

Description

Detect the method for landiolol hydrochloride optical isomers by high performance liquid chromatography
Technical field
The present invention relates to detect by high performance liquid chromatography the method for hydrochloride landiolol (Landiolol Hydrochloride) optical isomer, say more specifically and detect in the hydrochloride landiolol production run or the method for Landiolol Hydrochloride Isomer A (Isomer A), Landiolol Hydrochloride Isomer B (Isomer B) and Landiolol Hydrochloride Isomer C (Isomer C) in the hydrochloride landiolol product.
Figure GA20167942200910029421601D00011
Background technology
Hydrochloride landiolol is to carry out architecture advances on the esmolol hydrochloride basis and the noval chemical compound that obtains, its chemistry 4-[(2S by name)-and 2-hydroxyl-3-[[2-[(4-morpholine formyl) amino] ethyl] amino] propoxyl group] benzenpropanoic acid 4-[(4S)-2,2-dimethyl-1, the 3-dioxolane] methyl ester hydrochloride, molecular formula: C 25H 39N 3O 8HCl, molecular weight: 546.05, have selectivity β 1The receptor blocking effect does not have intrinsic sympathomimetic acitivity and membrane stabilizing action.The hydrochloride landiolol mechanism of action is that Main Function is in heart β 1Acceptor, and suppress the norepinephrine of SNE and adrenal medella release and the heart rate increase that adrenaline causes.The method that a lot of isomeride separate by high performance liquid chromatography is known, but the factors such as mobile phase, solvent, column temperature, chromatographic column have a significant impact for testing result or are not suitable for the target detection thing.
Summary of the invention
The purpose of this invention is to provide the method that detects gained hydrochloride landiolol A, B, C isomeride in the hydrochloride landiolol chirality is synthetic by high performance liquid chromatography, with the purity of control synthetic sample.
It is that fixedly the chiral column of phase detects that the present invention adopts Silica Surface to be coated with cellulose-three (4-methyl benzoic acid ester), and the hole in the cellulose esters class formation and passage and isomeride have optionally formed the isomeride inclusion compound, thereby reach separation.
Mobile phase all has a significant impact Landiolol Hydrochloride Isomer A, Landiolol Hydrochloride Isomer B and Landiolol Hydrochloride Isomer C degree of separation and peak shape in the experimental result, grope through inventor's experiment, determine with normal hexane-isopropyl alcohol-diethylamine (70~90: 10~30: 0.02~0.5, be preferably 75~85: 15~25: 0.05~0.2, more preferably 80: 20: 0.1) be that the mobile phase effect is fine.Wherein add diethylamine and can improve peak shape.
The selection of solvent and hydrochloride landiolol, hydrochloride landiolol A, B, C isomer separation degree are relevant.Determine to adopt n-propanol, isopropyl alcohol, ethanol, normal butyl alcohol, methyl alcohol to use solvent as dissolving through testing, preferably take isopropyl alcohol: methyl alcohol (50: 50) is solvent.
The actual conditions of the method that detects hydrochloride landiolol A, B, C isomeride by high performance liquid chromatography provided by the invention is as follows:
1. chromatographic condition: the chromatographic column adopting silica gel surface is coated with cellulose-three (4-methyl benzoic acid ester) and is the fixing chiral column of phase; Mobile phase is normal hexane-isopropyl alcohol-diethylamine (70~90: 10~30: 0.02~0.5, be preferably 75~85: 15~25: 0.05~0.2, more preferably 80: 20: 0.1); The detection wavelength is 200nm~240nm (being preferably 210nm~230nm, more preferably about 220nm); Column temperature is 20~40 ℃ (being preferably 30~40 ℃, more preferably 35 ℃); Flow rate of mobile phase is 0.5~2.0ml/min (being preferably 0.8~1.2ml/min, more preferably about 1.0ml/min).
2. the configuration of sample solution: adopt organic solvent (to be preferably selected from n-propanol, isopropyl alcohol, ethanol, normal butyl alcohol, methyl alcohol, isopropyl alcohol more preferably: methyl alcohol (50: 50)), sample ligand is made as the solution of the solution (preferred 1~3mg/ml, more preferably 2mg/ml) of hydrochloric Landiolol 0.5~5.0mg/ml.
3. measure: solution is injected high performance liquid chromatograph, the record chromatogram, and analyze.
Adopt this chromatographic condition to measure that Landiolol Hydrochloride Isomer A, Landiolol Hydrochloride Isomer B and Landiolol Hydrochloride Isomer C degree of separation can reach 1.5~3.9 in hydrochloride landiolol, meet the Chinese Pharmacopoeia requirement.This chromatographic condition can be used for the quantitative of landiolol hydrochloride optical isomers simultaneously.
Description of drawings
Fig. 1: the high-efficient liquid phase chromatogram that separates hydrochloride landiolol, Landiolol Hydrochloride Isomer A, Landiolol Hydrochloride Isomer B and Landiolol Hydrochloride Isomer C according to the condition of embodiment 1.(1) number peak is Landiolol Hydrochloride Isomer B, and (2) number peak is Landiolol Hydrochloride Isomer A, and (3) number peak is Landiolol Hydrochloride Isomer C, and (4) number peak is hydrochloride landiolol
Fig. 2: the high-efficient liquid phase chromatogram that separates hydrochloride landiolol, Landiolol Hydrochloride Isomer A, Landiolol Hydrochloride Isomer B and Landiolol Hydrochloride Isomer C according to the condition of embodiment 2.(1) number peak is Landiolol Hydrochloride Isomer B, and (2) number peak is Landiolol Hydrochloride Isomer A, and (3) number peak is Landiolol Hydrochloride Isomer C, and (4) number peak is hydrochloride landiolol
Embodiment
Embodiment 1.
Instrument: SHIMADZU LC-10AT high performance liquid chromatograph, SPD-10Avp UV-detector, OV-100 column oven;
Chromatographic column: Daicel Chralcel OJ-H chromatographic column (0.46 * 25cm, 5 μ m);
Mobile phase: normal hexane-isopropyl alcohol-diethylamine (80: 20: 0.1)
Column temperature: 35 ℃
Flow velocity: 1.0ml/min
Detect wavelength: 220nm.
The preparation of location solution 1: it is an amount of that precision takes by weighing your A isomeride of the blue ground of hydrochloric acid, dissolves and be diluted to 2mg/ml with isopropyl alcohol-methyl alcohol (50: 50);
The preparation of location solution 2: it is an amount of that precision takes by weighing your B isomeride of the blue ground of hydrochloric acid, dissolves and be diluted to 2mg/ml with isopropyl alcohol-methyl alcohol (50: 50);
The preparation of location solution 3: it is an amount of that precision takes by weighing your C isomeride of the blue ground of hydrochloric acid, dissolves and be diluted to 2mg/ml with isopropyl alcohol-methyl alcohol (50: 50);
The preparation of sample solution: precision takes by weighing the blue ground of hydrochloric acid, and you are an amount of, dissolve and are diluted to 2mg/ml with isopropyl alcohol-methyl alcohol (50: 50);
Measure: respectively get location solution 1, location solution 2, location solution 3 and each 20 μ l of sample solution and inject high performance liquid chromatograph, the record chromatogram, spectrogram is seen Fig. 1.Hydrochloride landiolol, hydrochloride landiolol A, B, C isomer separation degree are 1.5-2.9.
Embodiment 2.
Instrument: SHIMADZU LC-10AT high performance liquid chromatograph, SPD-10Avp UV-detector, OV-100 column oven;
Chromatographic column: AE.Lichrom OJ-H chromatographic column (0.46 * 25cm, 5 μ m);
Mobile phase: normal hexane-isopropyl alcohol-diethylamine (82: 18: 0.1)
Column temperature: 35 ℃
Flow velocity: 1.0ml/min
Detect wavelength: 220nm.
The preparation of location solution 1: it is an amount of that precision takes by weighing your A isomeride of the blue ground of hydrochloric acid, dissolves and be diluted to 2mg/ml with isopropyl alcohol-methyl alcohol (50: 50);
The preparation of location solution 2: it is an amount of that precision takes by weighing your B isomeride of the blue ground of hydrochloric acid, dissolves and be diluted to 2mg/ml with isopropyl alcohol-methyl alcohol (50: 50);
The preparation of location solution 3: it is an amount of that precision takes by weighing your C isomeride of the blue ground of hydrochloric acid, dissolves and be diluted to 2mg/ml with isopropyl alcohol-methyl alcohol (50: 50);
The preparation of sample solution: precision takes by weighing the blue ground of hydrochloric acid, and you are an amount of, dissolve and are diluted to 2mg/ml with isopropyl alcohol-methyl alcohol (50: 50);
Measure: respectively get location solution 1, location solution 2, location solution 3 and each 20 μ l of sample solution and inject high performance liquid chromatograph, the record chromatogram, spectrogram is seen Fig. 2.Hydrochloride landiolol, hydrochloride landiolol A, B, C isomer separation degree are 1.5-3.9.

Claims (12)

1. detect the method for landiolol hydrochloride optical isomers by high performance liquid chromatography, specific as follows:
1) chromatographic condition: the chromatographic column adopting silica gel surface is coated with cellulose-three (4-methyl benzoic acid ester) and is the fixing chiral column of phase; Mobile phase is normal hexane-isopropyl alcohol-diethylamine, and ratio is 70~90: 10~30: 0.02~0.5; The detection wavelength is 200nm~240nm; Column temperature is 20~40 ℃; Flow rate of mobile phase is 0.5~2.0ml/min;
2) preparation of sample solution: adopt organic solvent that sample ligand is made for the solution of hydrochloric Landiolol 0.5~5.0mg/ml, described organic solvent is selected from n-propanol, isopropyl alcohol, ethanol, normal butyl alcohol, methyl alcohol;
3) measure: solution is injected high performance liquid chromatograph, and the record chromatogram is also analyzed.
2. method according to claim 1 is characterized in that described mobile phase normal hexane-isopropyl alcohol-diethylamine ratio is 75~85: 15~25: 0.05~0.2.
3. method according to claim 2 is characterized in that described mobile phase normal hexane-isopropyl alcohol-diethylamine ratio is 80: 20: 0.1.
4. method according to claim 1, it is characterized in that detecting wavelength is 210nm~230nm.
5. method according to claim 4, it is characterized in that detecting wavelength is 220nm.
6. method according to claim 1 is characterized in that column temperature is 30~40 ℃.
7. method according to claim 6 is characterized in that column temperature is 35 ℃.
8. method according to claim 1 is characterized in that flow rate of mobile phase is 0.8~1.2ml/min.
9. method according to claim 8 is characterized in that flow rate of mobile phase is 1.0ml/min.
10. each described method is characterized in that the organic solvent that adopts in the preparation of sample solution is isopropyl alcohol-methyl alcohol according to claim 1-9, and ratio is 50: 50.
11. each described method according to claim 1-9 is characterized in that sample solution is formulated as the solution of hydrochloric Landiolol 1~3mg/ml.
12. method according to claim 11 is characterized in that sample solution is formulated as the solution of hydrochloric Landiolol 2mg/ml.
CN 200910029421 2009-04-13 2009-04-13 Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography Active CN101858892B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910029421 CN101858892B (en) 2009-04-13 2009-04-13 Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910029421 CN101858892B (en) 2009-04-13 2009-04-13 Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography

Publications (2)

Publication Number Publication Date
CN101858892A CN101858892A (en) 2010-10-13
CN101858892B true CN101858892B (en) 2013-04-10

Family

ID=42944911

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910029421 Active CN101858892B (en) 2009-04-13 2009-04-13 Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography

Country Status (1)

Country Link
CN (1) CN101858892B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102466659A (en) * 2010-11-15 2012-05-23 天津药物研究院 Method for detecting N-(N-benzoyl- phenylalanyl)-phenylalanine dipeptide derivative
CN102183594B (en) * 2011-02-23 2013-12-11 重庆植恩药业有限公司 Method for detecting landiolol hydrochloride optical isomer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101271085A (en) * 2007-03-21 2008-09-24 北京德众万全药物技术开发有限公司 Method for analytical separation of Landiolol Hydrochloride and its intermediate body by HPLC method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101271085A (en) * 2007-03-21 2008-09-24 北京德众万全药物技术开发有限公司 Method for analytical separation of Landiolol Hydrochloride and its intermediate body by HPLC method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
童立年.注射用盐酸兰地洛尔的细菌内毒素检查法.《中国药业》.2008,第17卷(第24期),29. *
赫冠男等.兰地洛尔的药理作用及其围手术期的应用.《中国新药与临床杂志》.2007,第26卷(第12期),942-945. *
高雁 华.兰地洛尔预防拔管期应激反应的效果观察.《医学信息手术学分册》.2007,第20卷(第2期),155-156. *

Also Published As

Publication number Publication date
CN101858892A (en) 2010-10-13

Similar Documents

Publication Publication Date Title
Ali et al. Polysaccharides chiral stationary phases in liquid chromatography
Ghanem et al. Application and comparison of immobilized and coated amylose tris-(3, 5-dimethylphenylcarbamate) chiral stationary phases for the enantioselective separation of β-blockers enantiomers by liquid chromatography
CN104634887A (en) Method for separating and measuring ticagrelor and optical isomer of ticagrelor
CN101858892B (en) Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography
Doi et al. Enantioseparation of the carboxamide-type synthetic cannabinoids N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide and methyl [1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-valinate in illicit herbal products
CN104764825A (en) Method for separating and detecting enantiomer of ezetimibe key intermediate
CN102890127A (en) Method for separating and measuring esomeprazole magnesium and optical isomer thereof by using liquid chromatography
CN103604895B (en) Method for analytical separation of (-) benzoyl Corey lactone optical isomers by HPLC
CN101881755B (en) Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography
Hefnawy et al. Enantioselective high-performance liquid chromatographic method for the determination of baclofen in human plasma
CN105675733A (en) Method for using liquid chromatography method for separation and determination of trelagliptin succinate and trelagliptin succinate optical isomers
Shangguan et al. Derivatization and fluorescence detection of amino acids and peptides with 9-fluorenylmethyl chloroformate on the surface of a solid adsorbent
CN104535673B (en) A kind of method of HPLC separation determination rosuvastain calcium enantiomter
CN103308636B (en) Quality control method of D-(+)-alpha-(2-thiofuran ethylamino)-alpha-(2-chlorphenyl) methyl acetate or salt thereof and application of D-(+)-alpha-(2-thiofuran ethylamino)-alpha-(2-chlorphenyl) methyl acetate or salt thereof in clopidogrel production
CN102928527A (en) Method for measuring optical purity of R-3-quinuclidine alcohol
CN102207494B (en) Method for simultaneously determining four optical isomers of palonosetron hydrochloride
CN101706478A (en) Method for testing isomer of palonosetron hydrochloride injection solution
CN101609071A (en) A kind of HPLC method analysis separates the method for ivabradine hydrochloride intermediate optical isomer
CN101769902A (en) Method for analyzing and separating optical isomer of pramipexole dihydrochloride by using HPLC method
CN103207247A (en) Method of separating and determining aliskiren intermediate and optical isomers thereof by using liquid chromatography
CN107505410A (en) The method that high performance liquid chromatography splits Nateglinide and its stereoisomer
CN101328161B (en) Method for separating and detecting nebivolol hydrochloride impurity by liquid phase chromatography
CN104483400B (en) Method for separating and measuring oxiracetam and intermediate thereof by liquid chromatography
CN102854261A (en) Method for separating and detecting duloxetine and optical isomer of duloxetine through liquid chromatography
CN108362789B (en) High performance liquid chromatography detection method for abamectin sodium optical isomer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NANJING HICIN PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: HAICHEN PHARMACEUTICAL CO., LTD., NANJING

CP01 Change in the name or title of a patent holder

Address after: 210046 Jiangsu province Nanjing HENGFA Nanjing economic and Technological Development Zone, Road No. 1

Patentee after: Nanjing hicin pharmaceutical Limited by Share Ltd

Address before: 210046 Jiangsu province Nanjing HENGFA Nanjing economic and Technological Development Zone, Road No. 1

Patentee before: Haichen Pharmaceutical Co., Ltd., Nanjing